National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

5/5/2010

Ellin Berman, MD

Novartis Pharmaceuticals Corporation

None

None

None

12/17/2009

Hossein Borghaei, DO, MS

Genentech, Inc.;
Spectrum

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

10/2/2009

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Enzon Pharmaceuticals;
Novartis Pharmaceuticals Corporation

None

None

1/5/2010

Marcel P. Devetten, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

12/30/2009

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation;
Takeda Pharmaceuticals North America, Inc.

None

None

9/29/2009

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

9/30/2009

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

Madan Jagasia, MD

None

None

None

None

10/18/2009

Joan S. McClure, MS

None

None

None

None

7/18/2010

Joseph O. Moore, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Susan O'Brien, MD

None

None

None

None

7/1/2009

Javier Pinilla-Ibarz, MD, PhD

Bristol-Myers Squibb Company;
Exelixis Inc.;
Novartis Pharmaceuticals Corporation;
Innovive

Novartis Pharmaceuticals Corporation;
Innovive

None

None

12/15/2009

Jerald P. Radich, MD

Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

12/1/2009

Neil P. Shah, MD, PhD

       

Pending

Paul J. Shami, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

12/10/2009

B. Douglas Smith, MD

Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Calistoga;
Infinity;
Infinity;
Merck Serono;
Synta Pharmaceuticals Corp.

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

3/23/2010

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

5/4/2010

Hema Sundar, PhD

None

None

None

Cephalon, Inc.

7/19/2010

Moshe Talpaz, MD

None

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/6/2009

Meir Wetzler, MD

Bristol-Myers Squibb Company;
ChemeGenix

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

12/6/2009

Furhan Yunus, MD, FACP

None

None

None

None

7/10/2009

 

NCCN Website Supporters